APYI: AI 评分 52/100 — AI 分析 (4月 2026)

Aspyra Inc. provides healthcare products and services, including software and hardware solutions, for the laboratory and imaging marketplaces. The company offers workflow solutions to specialty labs, clinics, hospitals, and imaging centers.

Key Facts: AI Score: 52/100 Sector: Healthcare

公司概况

概要：

Aspyra Inc. delivers engineered workflow solutions, encompassing software, hardware, and professional services, to the healthcare sector, specifically targeting labs, clinics, and imaging centers. Founded in 1978, the company focuses on providing integrated solutions for laboratory and imaging workflows, operating within a competitive healthcare IT landscape.

APYI是做什么的？

Aspyra Inc., established in 1978 and headquartered in Jacksonville, Florida, operates within the healthcare sector, providing a range of products and services tailored for the laboratory and imaging marketplaces. Originally named Creative Computer Applications Inc., the company rebranded as Aspyra Inc. in 2005 to better reflect its focus on integrated healthcare solutions. Aspyra's core offerings include engineered workflow solutions comprising software, interfaces, hardware, and professional services. These solutions are designed to optimize operations for a diverse clientele, including specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company's products facilitate efficient data management, streamlined workflows, and enhanced diagnostic capabilities within these healthcare settings. Aspyra's integrated approach aims to improve patient care and operational efficiency for its clients. With a history spanning over four decades, Aspyra has evolved to meet the changing needs of the healthcare industry, focusing on providing comprehensive solutions that address the specific challenges faced by laboratories and imaging centers. The company's commitment to innovation and customer satisfaction has allowed it to maintain a presence in the competitive healthcare IT market.

APYI的投资论点是什么？

Aspyra Inc. presents a focused play within the healthcare information services sector, offering specialized workflow solutions for labs and imaging centers. While the company's small market capitalization and OTC listing introduce inherent risks, its established presence since 1978 suggests a degree of stability. Key value drivers include the potential for increased adoption of its integrated software and hardware solutions by healthcare providers seeking to improve operational efficiency. However, the company's negative profit margin of -60.9% raises concerns about its financial sustainability. The beta of -51.48 indicates an inverse correlation with the market, which may offer diversification benefits but also reflects potential business-specific risks. Investors should closely monitor Aspyra's ability to achieve profitability and manage its cost structure.

APYI在哪个行业运营？

Aspyra Inc. operates within the healthcare information services industry, a sector experiencing growth driven by the increasing adoption of digital health solutions and the need for improved efficiency in healthcare workflows. The market is competitive, with established players and emerging startups vying for market share. Aspyra's focus on providing integrated solutions for labs and imaging centers positions it within a niche segment of the broader healthcare IT market. The industry is characterized by evolving regulatory requirements, technological advancements, and a growing emphasis on data security and interoperability.

Medical - Healthcare Information Services

Healthcare

APYI有哪些增长机遇？

Expansion into Telehealth Solutions: Aspyra can leverage its existing expertise in healthcare IT to develop and offer telehealth solutions, capitalizing on the growing demand for remote patient monitoring and virtual consultations. The telehealth market is projected to reach $55.6 billion by 2027, presenting a significant opportunity for Aspyra to diversify its revenue streams and expand its customer base. Timeline: 1-2 years.
Strategic Partnerships with Healthcare Providers: Aspyra can forge strategic partnerships with hospitals, clinics, and other healthcare providers to integrate its workflow solutions into their existing systems. These partnerships can provide Aspyra with access to a larger customer base and enhance its market visibility. Timeline: Ongoing.
Development of AI-Powered Diagnostic Tools: Aspyra can invest in the development of artificial intelligence (AI)-powered diagnostic tools to enhance the capabilities of its imaging solutions. AI-powered diagnostics can improve the accuracy and speed of image analysis, leading to better patient outcomes and increased efficiency for healthcare providers. Timeline: 2-3 years.
Geographic Expansion into Emerging Markets: Aspyra can expand its operations into emerging markets, where there is a growing demand for healthcare IT solutions. These markets offer significant growth potential due to increasing healthcare spending and a lack of established players. Timeline: 3-5 years.
Focus on Cybersecurity Solutions for Healthcare: With the increasing threat of cyberattacks on healthcare organizations, Aspyra can develop and offer cybersecurity solutions specifically tailored for the healthcare industry. This can help healthcare providers protect sensitive patient data and ensure the integrity of their systems. Timeline: 1-2 years.

Aspyra Inc. operates in the healthcare information services sector, providing specialized workflow solutions for labs and imaging centers.
The company was founded in 1978, indicating a long-standing presence in the healthcare IT market.
Aspyra's solutions include software, interfaces, hardware, and professional services, offering an integrated approach to healthcare workflows.
The company serves a diverse clientele, including specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices.
Aspyra Inc. has a negative profit margin of -60.9%, highlighting the need for improved financial performance.

APYI提供哪些产品和服务？

Provides healthcare products and services for the laboratory and imaging marketplaces.
Offers engineered workflow solutions that include software.
Provides hardware solutions for labs and imaging centers.
Offers professional services to support its products.
Serves specialty labs, reference labs, clinics, and hospitals.
Caters to imaging centers and orthopedic practices.

APYI如何赚钱？

Sells integrated software and hardware solutions to healthcare providers.
Generates revenue through professional services, including implementation and support.
Focuses on recurring revenue through software maintenance and upgrades.

Specialty labs
Reference labs
Hospitals and clinics
Imaging centers
Orthopedic practices

Established presence in the healthcare IT market since 1978.
Integrated solutions offering a comprehensive approach to healthcare workflows.
Specialized expertise in laboratory and imaging workflows.

什么因素可能推动APYI股价上涨？

Upcoming: Potential partnerships with larger healthcare providers to expand market reach.
Ongoing: Continued development and enhancement of existing software and hardware solutions.
Ongoing: Efforts to improve operational efficiency and reduce costs.

APYI的主要风险是什么？

Potential: Negative profit margin and financial instability.
Potential: Limited liquidity due to OTC listing.
Ongoing: Intense competition from larger and more established players.
Potential: Evolving regulatory requirements and technological advancements.
Potential: Cybersecurity threats and data privacy concerns.

APYI的核心优势是什么？

Long-standing presence in the healthcare IT market.
Integrated solutions encompassing software, hardware, and services.
Focus on specialized laboratory and imaging workflows.
Established customer base across various healthcare settings.

APYI的劣势是什么？

Negative profit margin indicating financial challenges.
Small market capitalization and OTC listing posing liquidity risks.
Limited brand recognition compared to larger competitors.
Dependence on a niche segment of the healthcare IT market.

APYI有哪些机遇？

Expansion into telehealth solutions.
Strategic partnerships with healthcare providers.
Development of AI-powered diagnostic tools.
Geographic expansion into emerging markets.

APYI面临哪些威胁？

Intense competition from larger and more established players.
Evolving regulatory requirements and technological advancements.
Cybersecurity threats and data privacy concerns.
Economic downturns impacting healthcare spending.

APYI的竞争对手是谁？

AccuStem Sciences Inc — Focuses on regenerative medicine. — (ACUS)
American Oriental Bioengineering Inc — Develops and markets veterinary medicines. — (AOBI)
Code On Demand Inc — Provides software development services. — (CDXI)
Internet Speech Inc — Offers voice recognition and speech synthesis technologies. — (ISHI)
Longboard Inc — Operates in the cannabis industry. — (LGBI)

Key Metrics

MoonshotScore: 52/100

Company Profile

CEO: Gary W. Bennett
Headquarters: Jacksonville, US
Employees: 69
Founded: 1983

AI Insight

AI analysis pending for APYI

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Aspyra Inc. do?

Aspyra Inc. specializes in providing healthcare IT solutions for the laboratory and imaging marketplaces. The company offers a suite of engineered workflow solutions, including software, hardware, and professional services, designed to streamline operations and improve efficiency for specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. Aspyra's integrated approach aims to enhance data management, workflow optimization, and diagnostic capabilities within these healthcare settings.

What do analysts say about APYI stock?

As of 2026-03-18, there is no readily available analyst coverage for Aspyra Inc. (APYI) due to its listing on the OTC Other tier and small market capitalization. The lack of analyst coverage means that investors must rely on their own research and due diligence to assess the company's prospects and valuation. Key metrics to consider include the company's financial performance, growth potential, and competitive positioning within the healthcare IT market.

What are the main risks for APYI?

Aspyra Inc. faces several risks, including its negative profit margin, which raises concerns about its financial sustainability. The company's OTC listing and small market capitalization pose liquidity risks and increase the potential for price volatility. Aspyra also faces intense competition from larger and more established players in the healthcare IT market. Additionally, evolving regulatory requirements, technological advancements, and cybersecurity threats present ongoing challenges for the company.